journal article·2021-06-23

Molybdenum Trioxide Quantum Dot-Encapsulated Nanogels for Virus Detection by Surface-Enhanced Raman Scattering on a 2D Substrate

Ojodomo J. Achadu, Fuyuki Abe, Tian-Cheng Li, Indra Memdi Khoris, Dongkyu Lee, Jaebeom Lee, Tetsuro Suzuki, Enoch Y. Park

ACS Applied Materials & Interfaces· Volume 13· Issue 24
Publisher page

Abstract

The use of nanogels (NGs) to modulate surface-enhanced Raman scattering (SERS) activities is introduced as an innovative strategy to address certain critical issues with SERS-based immunoassays. This includes the chemical deformation of SERS nanotags, as well as their nonspecific interactions and effective “hotspots” formation. Herein, the polymeric cocoon and stimuli-responsive properties of NGs were used to encapsulate SERS nanotags containing plasmonic molybdenum trioxide quantum dots (MoO3-QDs). The pH-controlled release of the encapsulated nanotags and their subsequent localization by maleimide-functionalized magnetic nanoparticles facilitated the creation of “hotspots” regions with catalyzed SERS activities. This approach resulted in developing a biosensing platform for the ultrasensitive immunoassays of hepatitis E virus (HEV) or norovirus (NoV). The immunoassays were optimized using the corresponding virus-like particles to attain limits of detection of 6.5 and 8.2 fg/mL for HEV-LPs and NoV-LPs, respectively. The SERS-based technique achieved a signal enhancement factor of up to ∼108 due to the combined electromagnetic and chemical mechanisms of the employed dual-SERS substrate of MoO3-QDs/2D hexagonal boron nitride nanosheets. The highlight and validation of the developed SERS-based immunoassays was the detection of NoV in infected patients’ fecal specimen and clinical HEV G7 subtype. Importantly, this system can be used to maintain the stability of SERS nanotags and improve their reliability in immunoassays.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Extracellular vesicles in disease · COVID-19 Impact on Reproduction

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya Suruga-ku, Shizuoka 422-8529, Japan

Department of Microbiology, Shizuoka Institute of Environment and Hygiene, 232-1, Yainaba, Fujieda 426-0083, Japan

Department of Virology 2, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayam-shi, Tokyo 208-0011, Japan

Laboratory of Biotechnology, Department of Bioscience, Graduate School of Science and Technology, Shizuoka University, 836 Ohya Suruga-ku, Shizuoka 422-8529, Japan

Department of Chemistry, College of Natural Science, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Korea

Department of Infectious Diseases, Hamamatsu University School of Medicine, 1-20-1 Higashi-ku, Handa-yama, Hamamatsu 431-3192, Japan

Funding

Japan Society for the Promotion of Science

References (47)

Show source-provided references
1. 10.1039/C7CS00786H10.1039/C7CS00786H ↗
2. 10.1039/C7CS00207F10.1039/C7CS00207F ↗
3. Khlebtsov N. G. · Theranostics · 2020 · 10 · 206710.7150/thno.39968 ↗
4. 10.1039/b708459p10.1039/b708459p ↗
5. 10.1039/C5NR08674D10.1039/C5NR08674D ↗
6. Lee C. · Nanoscale · 2015 · 9 · 929010.1039/C5NR01333J ↗
7. 10.1039/C5CS00828J10.1039/C5CS00828J ↗
8. 10.1039/c3an36866a10.1039/c3an36866a ↗
9. 10.1088/0957-4484/23/11/11550110.1088/0957-4484/23/11/115501 ↗
10. 10.1016/j.talanta.2006.11.00210.1016/j.talanta.2006.11.002 ↗
11. 10.1515/revac-2016-002710.1515/revac-2016-0027 ↗
12. 10.1149/2.0161808jes10.1149/2.0161808jes ↗
13. 10.1021/ac034356f10.1021/ac034356f ↗
14. 10.1039/b708461g10.1039/b708461g ↗
15. Yu H. · NPJ Comput. Mater. · 2019 · 5 · 4510.1038/s41524-019-0184-1 ↗
16. 10.1039/D0NR07779H10.1039/D0NR07779H ↗
17. 10.1007/s10853-020-04669-510.1007/s10853-020-04669-5 ↗
18. 10.1039/C6AN01959E10.1039/C6AN01959E ↗
19. 10.1021/acsami.0c1472910.1021/acsami.0c14729 ↗
20. 10.1039/C7TC04807F10.1039/C7TC04807F ↗
21. 10.1002/adma.20190235210.1002/adma.201902352 ↗
22. 10.1002/adma.20170694510.1002/adma.201706945 ↗
23. 10.1016/j.nantod.2019.02.01210.1016/j.nantod.2019.02.012 ↗
24. 10.1002/adfm.20180732610.1002/adfm.201807326 ↗
25. 10.1021/acsami.8b1566110.1021/acsami.8b15661 ↗
26. 10.1021/acsami.9b1489210.1021/acsami.9b14892 ↗
27. 10.1021/acsami.0c0728810.1021/acsami.0c07288 ↗
28. 10.1021/am501093a10.1021/am501093a ↗
29. 10.1021/acsami.6b1036010.1021/acsami.6b10360 ↗
30. 10.1016/S1872-2067(20)63566-510.1016/S1872-2067(20)63566-5 ↗
31. 10.1016/j.snb.2020.12849410.1016/j.snb.2020.128494 ↗
32. 10.1016/j.talanta.2017.01.03110.1016/j.talanta.2017.01.031 ↗
33. 10.1007/s00604-020-04433-110.1007/s00604-020-04433-1 ↗
34. 10.1021/acsnano.6b0615310.1021/acsnano.6b06153 ↗
35. 10.1002/anie.20160051710.1002/anie.201600517 ↗
36. 10.1016/j.aca.2017.07.04710.1016/j.aca.2017.07.047 ↗
37. 10.1007/s10895-016-1916-y10.1007/s10895-016-1916-y ↗
38. 10.1021/acsami.7b1661810.1021/acsami.7b16618 ↗
39. 10.1002/mabi.20190027210.1002/mabi.201900272 ↗
40. 10.1021/am201747d10.1021/am201747d ↗
41. 10.1039/C5TC01759A10.1039/C5TC01759A ↗
42. 10.1039/C8NJ04105A10.1039/C8NJ04105A ↗
43. 10.1021/acs.biomac.8b0019510.1021/acs.biomac.8b00195 ↗
44. 10.1039/C6NR08693D10.1039/C6NR08693D ↗
45. 10.1039/C3NR06316J10.1039/C3NR06316J ↗
46. 10.1039/c3nr02924g10.1039/c3nr02924g ↗
47. 10.1016/j.jconrel.2018.03.00210.1016/j.jconrel.2018.03.002 ↗